Closed · HR001121S0038 · CFDA 12.910 · Discretionary
Reimagining Protein Manufacturing (RPM)
Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- November 16, 2021
- Close date
- -
- Expected awards
The verdict
Reimagining Protein Manufacturing (RPM) is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 73 other opportunities from DARPA - Biological Technologies Office.
- Varies
- award range
- Closed
- application status
- 12.910
- CFDA program
- 73
- other opportunities from DARPA - Biological Technologies Office
Archived opportunity record
Reimagining Protein Manufacturing (RPM) is closed (last close November 16, 2021). Check the agency catalog for replacement NOFOs. DARPA - Biological Technologies Office still indexes 73 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed November 16, 2021
Instrument
Procurement Contract
Description
The Reimagining Protein Manufacturing (RPM) program aims to ensure timely DoD access to critical medical countermeasures (MCMs) by establishing the foundational technologies needed for fully distributed, on-demand manufacturing of protein-based MCMs and associated raw materials. To achieve this goal, RPM will develop technologies to enable immediate synthesis (lead time approximately 24 hours) of bioactive protein MCMs and raw material production enzymes at a yield corresponding to > 500 doses per week. This technology will allow the DoD to rapidly secure access to both therapeutic proteins and enzymes needed for nucleic acid-based MCM synthesis, and reduce reliance on complex supply chains.
Catch-all / unrestricted eligibility mark · HR001121S0038
Grants.gov marks Reimagining Protein Manufacturing (RPM) with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Biological Technologies Office book (44 peers, 59% of 74).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
BAA Coordinator RPM@darpa.mil
More from DARPA - Biological Technologies Office
What to do next
Reimagining Protein Manufacturing (RPM) is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |